Beth Feldpush News Today

Healthcare

An appeals court has upheld a lower court ruling on 340B that sided with drug manufacturers. At issue is whether pharmaceutical companies can limit distribution of discounted drugs in the 340B program. The U.S. Court of Appeals for the District of Columbia has said that they can. The May 21 ruling issued by Circuit Court Judge Gregory Katsas found for Novartis Pharmaceuticals

Denver Health officials, Colorado lawmakers, health care experts and city officials spoke about the city’s safety-net hospital financial predicament, what could happen if it failed and what it would take to stabilize the health system.

CMS finalized a $9 billion lump sum payment to 1,700 hospitals participating in the 340B Drug Pricing Program to make them whole from unlawful payment cuts from 2018 to 2022. 

With an average operating margin of −8.6 percent, charity care and other uncompensated care leaves Americas essential hospitals deep in the red.

It has become as familiar a sight in Washington as the cherry blossoms in spring: lobbyists from the nation’s hospitals descending on the Capitol to ask lawmakers to postpone billions

It has become as familiar a sight in Washington as the cherry blossoms in spring: lobbyists from the nation’s hospitals descending on the Capitol to ask lawmakers to postpone billions

Congress has until October to avert cuts to a Medicaid program intended to support safety-net hospitals.

It has become as familiar a sight in Washington as the cherry blossoms in spring: lobbyists from the nation's hospitals descending on the Capitol to ask lawmakers to postpone billions in Medicaid funding cuts prescribed by the Affordable Care Act — cuts industry leaders agreed to years ago.

Congress has until October to avert cuts to a Medicaid program intended to support safety-net hospitals that, in practice, improves the bottom lines of other hospitals, too. Hospital leaders say now is not a good time for the cuts — which lawmakers have so far postponed 13 times.